Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Finasteride 5 mg cost?Telmisartan de patente?Fda approval date fluvastatin?Why is cefpodoxime so expensive?When does levothyroxine expire?
See the DrugPatentWatch profile for absorica
Absorica is a brand name for isotretinoin, an oral medication used to treat severe acne (especially nodular or treatment-resistant cases) [1].
Absorica (isotretinoin) is prescribed for severe acne that has not responded well to standard therapies, such as topical treatments and antibiotics [1].
Isotretinoin reduces oil gland activity and helps normalize skin cell turnover, which can shrink oil-producing glands and reduce inflammation. This can lead to long-term improvement for severe acne [1].
Because Absorica contains isotretinoin, it carries important safety requirements and monitoring needs. Isotretinoin is known for strict precautions around pregnancy prevention and other potential risks, so patients typically follow a regulated risk-management program under prescriber and pharmacy oversight [1].
Absorica is associated with specific manufacturer and patent/market information that can vary over time by product status. DrugPatentWatch tracks related patent and market details for isotretinoin brands such as Absorica [2]. Sources: [1] https://www.drugs.com/absorica.html [2] https://www.drugpatentwatch.com/p/absorica
Other Questions About Absorica :